About Rhythm Pharmaceuticals
Rhythm Pharmaceuticals is a company based in Boston (United States) founded in 2010.. Rhythm Pharmaceuticals has raised $84 million across 9 funding rounds from investors including HHS, Ipsen and Orbimed. The company has 283 employees as of December 31, 2024. Rhythm Pharmaceuticals has completed 1 acquisition, including Xinvento. Rhythm Pharmaceuticals offers products and services including IMCIVREE and Clinical Trials.
- Headquarter Boston, United States
- Employees 283 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rhythm Pharmaceuticals, Inc.
-
Annual Revenue
$130.13 M68.06as on Dec 31, 2024
-
Net Profit
$-260.6 M-41.11as on Dec 31, 2024
-
EBITDA
$-263.94 M-44.55as on Dec 31, 2024
-
Total Equity Funding
$84 M (USD)
in 9 rounds
-
Latest Funding Round
$150 M (USD), Post-IPO
Apr 01, 2024
-
Investors
HHS
& 9 more
-
Employee Count
283
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Rhythm Pharmaceuticals
Rhythm Pharmaceuticals is a publicly listed company on the NASDAQ with ticker symbol RYTM in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Rhythm Pharmaceuticals
Rhythm Pharmaceuticals offers a comprehensive portfolio of products and services, including IMCIVREE and Clinical Trials. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
IMCIVREE is utilized as a treatment for rare obesity disorders associated with neuroendocrine diseases
Clinical trials are conducted by Rhythm Pharmaceuticals to advance treatments for hyperphagia and obesity
Unlock access to complete
Unlock access to complete
Funding Insights of Rhythm Pharmaceuticals
Rhythm Pharmaceuticals has successfully raised a total of $84M across 9 strategic funding rounds. The most recent funding activity was a Post-IPO round of $150 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Post-IPO — $150.0M
-
First Round
First Round
(15 Mar 2010)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Post-IPO - Rhythm Pharmaceuticals | Valuation |
investors |
|
| Feb, 2017 | Amount | Debt – Venture - Rhythm Pharmaceuticals | Valuation |
investors |
|
| Jul, 2015 | Amount | Grant - Rhythm Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rhythm Pharmaceuticals
Rhythm Pharmaceuticals has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Ipsen and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rhythm Pharmaceuticals
Rhythm Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Xinvento. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapies for congenital hyperinsulinism are researched and developed.
|
2021 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Rhythm Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rhythm Pharmaceuticals Comparisons
Competitors of Rhythm Pharmaceuticals
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rhythm Pharmaceuticals
Frequently Asked Questions about Rhythm Pharmaceuticals
When was Rhythm Pharmaceuticals founded?
Rhythm Pharmaceuticals was founded in 2010.
Where is Rhythm Pharmaceuticals located?
Rhythm Pharmaceuticals is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of Rhythm Pharmaceuticals?
David Meeker is the current CEO of Rhythm Pharmaceuticals.
Is Rhythm Pharmaceuticals a funded company?
Rhythm Pharmaceuticals is a funded company, having raised a total of $84M across 9 funding rounds to date. The company's 1st funding round was a Grant of $999.35K, raised on Mar 15, 2010.
How many employees does Rhythm Pharmaceuticals have?
As of Dec 31, 2024, the latest employee count at Rhythm Pharmaceuticals is 283.
What is the annual revenue of Rhythm Pharmaceuticals?
Annual revenue of Rhythm Pharmaceuticals is $130.13M as on Dec 31, 2024.
What does Rhythm Pharmaceuticals do?
Developer of peptide therapeutics for the treatment of rare genetic deficiencies. It offers a lead peptide product candidate setmelanotide which is a potent, first-in-class melanocortin-4 receptor (MC4R) agonist for the treatment of Prader-Willi syndrome (PWS) and pro-opiomelanocortin deficiency obesity.
What products or services does Rhythm Pharmaceuticals offer?
Rhythm Pharmaceuticals offers IMCIVREE and Clinical Trials.
Is Rhythm Pharmaceuticals publicly traded?
Yes, Rhythm Pharmaceuticals is publicly traded on NASDAQ under the ticker symbol RYTM.
How many acquisitions has Rhythm Pharmaceuticals made?
Rhythm Pharmaceuticals has made 1 acquisition, including Xinvento.
Who are Rhythm Pharmaceuticals's investors?
Rhythm Pharmaceuticals has 10 investors. Key investors include HHS, Ipsen, Orbimed, The Michael J. Fox Foundation, and Perceptive Advisors.
What is Rhythm Pharmaceuticals's ticker symbol?
The ticker symbol of Rhythm Pharmaceuticals is RYTM on NASDAQ.